Benralizumab for eosinophilic gastritis: a single-site, randomised, double-blind, placebo-controlled, phase 2 trial. The Lancet Gastroenterology and Hepatology. 2023; 8(9):803-815.
One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trial. The Lancet Gastroenterology and Hepatology. 2023; 8(5):408-421.
Molecular analysis of duodenal eosinophilia. Journal of Allergy and Clinical Immunology. 2023; 151(4):1027-1039.
Mast cell-pain connection in eosinophilic esophagitis. Allergy. European Journal of Allergy and Clinical Immunology. 2022; 77(6):1895-1899.
Evaluating Eosinophilic Colitis as a Unique Disease Using Colonic Molecular Profiles: A Multi-Site Study. Gastroenterology. 2022; 162(6):1635-1649.
Loss of Endothelial TSPAN12 Promotes Fibrostenotic Eosinophilic Esophagitis via Endothelial Cell-Fibroblast Crosstalk. Gastroenterology. 2022; 162(2):439-453.
Diagnostic merits of the Eosinophilic Esophagitis Diagnostic Panel from a single esophageal biopsy. Journal of Allergy and Clinical Immunology. 2022; 149(2):782-787.e1.
Desmoplakin and periplakin genetically and functionally contribute to eosinophilic esophagitis. Nature Communications. 2021; 12(1):6795.
Molecular, endoscopic, histologic, and circulating biomarker-based diagnosis of eosinophilic gastritis: Multi-site study. Journal of Allergy and Clinical Immunology. 2020; 145(1):255-269.
Eosinophilic oesophagitis endotype classification by molecular, clinical, and histopathological analyses: a cross-sectional study. The Lancet Gastroenterology and Hepatology. 2018; 3(7):477-488.
Effects of Proton Pump Inhibitors on Remodeling and Fibrosis in Eosinophilic Esophagitis. Journal of Allergy and Clinical Immunology. 2026.
Epigenetic and transcriptional programming of murine eosinophils in the esophagus. Nature Communications. 2025; 16(1):10454.
Involvement of IL-13-Induced Dysregulation of BDNF-NTRK2 Pathway in Symptoms of Eosinophilic Esophagitis. Allergy. European Journal of Allergy and Clinical Immunology. 2025; 80(10):2894-2897.
One-food versus 4-food elimination diet for pediatric eosinophilic esophagitis: A multisite randomized trial. Journal of Allergy and Clinical Immunology. 2025; 155(2):520-532.
Nonepithelial Gene Expression Correlates With Symptom Severity in Adults With Eosinophilic Esophagitis. Journal of Allergy and Clinical Immunology: In Practice. 2024; 12(12):3346-3355.e1.
Induction of sustained remission and reversal of pathologic transcriptome achieved with tezepelumab in an adolescent with eosinophilic esophagitis. Journal of Allergy and Clinical Immunology: In Practice. 2024; 12(11):3147-3149.e2.
Advances in omics data for eosinophilic esophagitis: moving towards multi-omics analyses. Journal of Gastroenterology. 2024; 59(11):963-978.
Losartan Treatment Reduces Esophageal Eosinophilic Inflammation in a Subset of Eosinophilic Esophagitis. Journal of Allergy and Clinical Immunology: In Practice. 2024; 12(9):2427-2438.e3.
Clinical and molecular correlates of the Index of Severity for Eosinophilic Esophagitis. Journal of Allergy and Clinical Immunology. 2024; 154(2):375-386.e4.
Eosinophil Involvement Outside the Esophagus in Eosinophilic Esophagitis. Clinical Gastroenterology and Hepatology. 2024; 22(7):1531-1534.e2.
Common and disparate clinical presentations and mechanisms in different eosinophilic gastrointestinal diseases. Journal of Allergy and Clinical Immunology. 2024; 153(6):1472-1484.
Persistent esophageal changes after histologic remission in eosinophilic esophagitis. Journal of Allergy and Clinical Immunology. 2024; 153(4):1063-1072.
The minichromosome maintenance complex drives esophageal basal zone hyperplasia. JCI Insight. 2023; 8(17).
Prospective study of an amino acid-based elemental diet in an eosinophilic gastritis and gastroenteritis nutrition trial. Journal of Allergy and Clinical Immunology. 2023; 152(3):676-688.
Benralizumab for eosinophilic gastritis: a single-site, randomised, double-blind, placebo-controlled, phase 2 trial. The Lancet Gastroenterology and Hepatology. 2023; 8(9):803-815.
Local type 2 immunity in eosinophilic gastritis. Journal of Allergy and Clinical Immunology. 2023; 152(1):136-144.
Vitamin D receptor and STAT6 interactome governs oesophageal epithelial barrier responses to IL-13 signalling. Gut. 2023; 72(5):834-845.
Genetic and Molecular Contributors in Eosinophilic Esophagitis. Current Allergy and Asthma Reports. 2023; 23(5):255-266.
One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trial. The Lancet Gastroenterology and Hepatology. 2023; 8(5):408-421.
Molecular analysis of duodenal eosinophilia. Journal of Allergy and Clinical Immunology. 2023; 151(4):1027-1039.
Epithelial cell-expressed type II IL-4 receptor mediates eosinophilic esophagitis. Allergy. European Journal of Allergy and Clinical Immunology. 2023; 78(2):464-476.
Strong association of mast cells with eosinophilic esophagitis-specific signatures. Allergy. European Journal of Allergy and Clinical Immunology. 2023; 78(2):583-586.
Single-cell RNA sequencing of mast cells in eosinophilic esophagitis reveals heterogeneity, local proliferation, and activation that persists in remission. Journal of Allergy and Clinical Immunology. 2022; 149(6):2062-2077.
Mast cell-pain connection in eosinophilic esophagitis. Allergy. European Journal of Allergy and Clinical Immunology. 2022; 77(6):1895-1899.
Evaluating Eosinophilic Colitis as a Unique Disease Using Colonic Molecular Profiles: A Multi-Site Study. Gastroenterology. 2022; 162(6):1635-1649.
Prospective Endoscopic Activity Assessment for Eosinophilic Gastritis in a Multisite Cohort. American Journal of Gastroenterology. 2022; 117(3):413-423.
Loss of Endothelial TSPAN12 Promotes Fibrostenotic Eosinophilic Esophagitis via Endothelial Cell-Fibroblast Crosstalk. Gastroenterology. 2022; 162(2):439-453.
Diagnostic merits of the Eosinophilic Esophagitis Diagnostic Panel from a single esophageal biopsy. Journal of Allergy and Clinical Immunology. 2022; 149(2):782-787.e1.